What Causes Fasting Insulin to Be Out of Range?: How to Read the Number and What to Do About It

What Fasting Insulin Actually Measures — and Why Labs Often Get It Wrong

Fasting insulin is measured after at least 8–12 hours without food or caloric beverages. The test captures how much insulin your pancreas needs to secrete just to maintain baseline blood sugar while you're in a rested, unfed state. In a metabolically healthy person, that baseline is low — because insulin-sensitive cells respond to small amounts of the hormone efficiently.

The problem is that most commercial labs flag fasting insulin as 'normal' anywhere up to 24–25 µIU/mL. Clinical researchers and metabolic medicine specialists increasingly view that ceiling as far too permissive. A landmark analysis published in Diabetes Care found that individuals with fasting insulin above 15 µIU/mL were significantly more likely to meet criteria for insulin resistance even when fasting glucose remained in the normal range (Ferrannini et al., Diabetes Care 2011; PMID: 21270176). In other words, your fasting glucose can look fine while your insulin is already working overtime.

The functional optimal range most integrative clinicians now target is 2–6 µIU/mL, with values between 6–10 µIU/mL considered borderline and anything above 10 µIU/mL deserving active investigation — especially when combined with elevated triglycerides, low HDL, or increasing waist circumference.

---

What Causes High Fasting Insulin?

Elevated fasting insulin — sometimes called hyperinsulinemia — rarely has a single cause. It reflects a progressive mismatch between how much insulin your pancreas produces and how sensitively your cells respond to it. The most common drivers include:

1. Dietary Carbohydrate Load and Refined Sugar

Chronically high intake of rapidly digested carbohydrates — white bread, sweetened beverages, ultra-processed snacks — demands repeated, large insulin secretions. Over time, skeletal muscle, liver, and fat cells down-regulate their insulin receptors and post-receptor signaling pathways, requiring more insulin to do the same job. A systematic review in PLOS ONE (Schwingshackl & Hoffmann 2013; PMID: 24339922) confirmed that low-glycemic dietary patterns significantly reduced fasting insulin compared to conventional diets, independent of caloric intake.

2. Excess Visceral Adipose Tissue

Fat stored inside the abdominal cavity (visceral fat, not subcutaneous fat) is metabolically active in a damaging way. It releases free fatty acids directly into the portal circulation and secretes pro-inflammatory cytokines like TNF-α and IL-6 that directly impair insulin receptor signaling in the liver. A 2012 study in Obesity demonstrated that visceral fat volume was a stronger predictor of fasting hyperinsulinemia than total body fat percentage (Neeland et al., Obesity 2012; PMID: 22538122).

3. Physical Inactivity

Skeletal muscle is the largest site of insulin-stimulated glucose disposal. When muscles are undertrained, glucose transporter (GLUT4) density on muscle cell membranes drops, forcing the pancreas to secrete more insulin to clear the same glucose load. A single bout of aerobic exercise can improve insulin sensitivity for 24–72 hours — a window worth protecting deliberately.

4. Poor Sleep and Circadian Disruption

Sleep deprivation directly suppresses insulin sensitivity. A controlled crossover trial found that just one week of sleeping 4.5 hours per night reduced whole-body insulin sensitivity by approximately 16% in healthy adults (Buxton et al., Annals of Internal Medicine 2010; PMID: 20921542). Shift workers and people with obstructive sleep apnea carry disproportionately high rates of fasting hyperinsulinemia.

5. Chronic Stress and Cortisol Elevation

Elevated cortisol counters insulin action at the receptor and post-receptor level and promotes visceral fat deposition. HPA axis dysregulation — a pattern commonly seen in burnout, anxiety disorders, and overtraining — can chronically push fasting insulin upward even when diet and exercise look adequate.

6. Thyroid Dysfunction

Both hypothyroidism and subclinical hypothyroidism slow glucose metabolism and alter insulin clearance. If your fasting insulin is elevated and you have unexplained fatigue, cold sensitivity, or rising triglycerides, a full thyroid panel (TSH, Free T3, Free T4) is worth requesting alongside metabolic markers.

---

What Causes Fasting Glucose to Be Out of Range?

Fasting glucose and fasting insulin are related but tell different parts of the story. Fasting glucose rises later in the progression of insulin resistance — by the time it climbs above 100 mg/dL (the prediabetes threshold), insulin has often been elevated for years.

Drivers of elevated fasting glucose overlap with those for high insulin but add a few distinct mechanisms:

• Hepatic glucose output: The liver produces glucose overnight via gluconeogenesis. In insulin-resistant states, the liver fails to suppress this production appropriately, so glucose leaks into the bloodstream even during a fast.
• Dawn phenomenon: A physiological surge of growth hormone and cortisol between 4–8 AM can raise fasting glucose in people predisposed to insulin resistance.
• Medications: Corticosteroids, some antipsychotics, thiazide diuretics, and beta-blockers can elevate fasting glucose independently of lifestyle.
• Low magnesium status: Magnesium is a cofactor for over 300 enzymatic reactions, including insulin receptor phosphorylation. Population data consistently show that low dietary magnesium intake correlates with higher fasting glucose and greater insulin resistance risk (Barbagallo & Dominguez, Archives of Biochemistry and Biophysics 2015; PMID: 25975353).

The optimal fasting glucose target in a metabolically healthy individual is 70–85 mg/dL, not simply 'under 100 mg/dL.' When viewed alongside HOMA-IR (fasting insulin × fasting glucose ÷ 405), you get a far more sensitive picture of metabolic function than either number alone.

---

What Causes A1C to Be Out of Range?

A1C (glycated hemoglobin) reflects the average percentage of hemoglobin molecules coated with glucose over approximately 90 days. The ADA defines a normal A1C as below 5.7%, prediabetes as 5.7–6.4%, and diabetes as 6.5% or above. But — similar to fasting insulin — the optimal for longevity and metabolic protection is likely in the 4.8–5.4% range based on data from large cohort studies.

A1C rises out of range when glucose chronically runs high enough to glycate red blood cells at an accelerated rate. Root causes include all the same lifestyle, hormonal, and dietary factors discussed above. However, A1C has important limitations:

• Hemoglobin variants (including sickle cell trait) artificially lower A1C readings
• Iron deficiency anemia increases red blood cell turnover and can falsely lower A1C
• Recent blood transfusions reset the 90-day window
• Chronic low-grade inflammation can elevate A1C slightly without true glucose dysregulation

For this reason, A1C should always be interpreted alongside fasting insulin, fasting glucose, and ideally a continuous glucose monitor (CGM) snapshot or glucose tolerance test — not in isolation.

If you want to understand how your full glucose panel connects to other cardiometabolic markers, reading your metabolic blood panel results offers a useful framework.

---

What Causes LDL Particle Number to Be Out of Range?

This secondary marker deserves inclusion here because insulin resistance is one of its most under-recognized drivers. LDL particle number (LDL-P), measured on an NMR LipoProfile, counts the actual number of LDL particles in circulation rather than the amount of cholesterol they carry. Small, dense LDL particles are far more atherogenic than large, buoyant ones — and insulin resistance specifically promotes the production of small dense LDL through its effects on triglyceride-rich VLDL metabolism.

Here's the pathway: high insulin → elevated triglycerides → cholesterol ester transfer protein (CETP) activity → triglyceride-enriched LDL → small, dense LDL particles that are numerous and oxidation-prone. This is why a person can have a 'normal' LDL-C (cholesterol mass) but a dangerously elevated LDL-P — a discordance that is far more common in people with hyperinsulinemia.

Targets for LDL particle number vary by cardiovascular risk:

Addressing the insulin root cause — not just adding a statin — is the metabolically coherent strategy for discordant LDL-P. For a deeper look at how lipid panels connect to cardiovascular risk, understanding your cholesterol panel and LDL subtypes provides additional context.

---

What This Means for Your Formula

This is where precision supplementation — based on your actual lab values rather than generic wellness logic — makes a meaningful difference.

At Ones, an AI health practitioner analyzes your blood work (including fasting insulin, glucose, A1C, and lipid panels where available) alongside wearable data and health history to identify which biological systems need targeted support. For the metabolic picture described in this article, several ingredients in the Ones catalog are directly relevant:

• Berberine (500mg): This alkaloid activates AMPK — the same pathway targeted by metformin — and has demonstrated clinically meaningful reductions in fasting insulin and glucose. A meta-analysis of 27 randomized trials found berberine significantly reduced fasting glucose, A1C, and triglycerides compared to placebo or lifestyle alone (Dong et al., Evidence-Based Complementary and Alternative Medicine 2012; PMID: 23118705). Ones includes berberine at clinically studied doses when metabolic markers indicate it is appropriate.
• Magnesium Glycinate (as part of the Magnesium Complex blend): Given magnesium's direct role as a cofactor in insulin receptor signaling and the strong epidemiological link between low magnesium and elevated fasting glucose, this is a frequent inclusion in Ones formulas where labs or diet history suggest insufficient intake.
• Omega-3 (EPA/DHA): Beyond cardiovascular benefits, omega-3 fatty acids at doses of 2–4g/day have been shown to reduce triglycerides — a key downstream marker of insulin resistance — and improve hepatic fat metabolism. Ones sources pharmaceutical-grade EPA/DHA and doses it based on the individual's lipid panel, not a one-size-fits-all milligram count.

Because Ones formulas are calibrated to capsule budgets (6- or 9-capsule daily plans selected by the AI based on your findings), every slot is allocated based on where the evidence and your specific numbers point — not a generic metabolic template.

For those exploring how wearable and lab data combine to drive formula decisions, how Ones uses blood work to build your supplement formula explains the process in more detail.

---

Key Takeaways

• Standard lab 'normal' ranges for fasting insulin are too broad — the functional optimal is 2–6 µIU/mL, and anything above 10 µIU/mL warrants investigation even if glucose looks fine.
• High fasting insulin is almost always multifactorial, with diet quality, visceral fat, inactivity, poor sleep, and chronic stress as the most common modifiable drivers.
• Fasting glucose and A1C rise later in metabolic dysfunction; fasting insulin is the earlier, more sensitive signal — always look at them together.
• LDL particle number is directly influenced by insulin resistance through triglyceride-driven VLDL metabolism; discordant LDL-C vs. LDL-P often points to hyperinsulinemia as the root cause.
• Magnesium status, omega-3 intake, and berberine are among the best-studied supplement-level interventions for improving insulin sensitivity — but doses and necessity should be guided by labs, not guesswork.
• Consult a qualified healthcare provider before making significant changes to your metabolic protocol, especially if you are on glucose-lowering medications or have a confirmed diagnosis of diabetes or prediabetes.